The authors summarize currently available catheter-based treatments for mitral regurgitation. The options are numerous and are evolving rapidly.
Commentary:
http://www.jtcvsonline.org/article/S0022-5223%2816%2930318-X/fulltext
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Mitral valve disease
June 11, 2016
June 2, 2016
Francis Wells of Papworth Hospital, Cambridge, United Kingdom, gives an in-depth talk on the anatomy of the mitral valve and the importance of mitral clefts.
May 31, 2016
This video shows a minimally invasive mitral valve repair with a standardized loop technique for neochordae.
May 5, 2016
This article summarizes the current status of robotic approaches to mitral valve repair. The technique is suitable to all types of degenerative mitral valve disease, and the outcomes are similar to those for open repair.
March 28, 2016
A refreshing , adequately supported by pragmatic imaging, 22 minute presentation from an Arizona meeting that many surgeons would find quite informative and educating. Dr.
March 10, 2016
This video show a mitral valve repair in a 64-year-old woman with class III dyspnea and severe mitral regurgitation.
March 2, 2016
Friedrich Mohr of the Heart Center, Leipzig, Germany, discusses his 18 years of experience performing minimally invasive mitral valve surgery.
January 30, 2016
3D echo was used to preoperatively assess the likelihood of recurrent MR after ring annuloplasty for ischemic MR. Recurrence was asssociated with P3 tethering angle greater than 29.9 degrees (accuracy 92%). The authors suggest that valve replacement rather than ring annuloplasty should be considered in such patients.
January 21, 2016
In a debate filmed at the 2015 SCTS Annual Meeting in Manchester, United Kingdom, Friedrich-Wilhelm Mohr and Francis Wells offer different perspectives on how best to treat non-complex degenerative mitral valve disease.
December 10, 2015
The study was a single-arm, multicentre, prospective study enrolling 31 high-risk adult individuals with symptomatic mitral regurgitation despite optimal medical therapy from five institutions in Europe. The primary efficacy endpoints included: (a) Technical success rate of the device implantation; (b) Technical feasibility of Cardioband adjustment;